Chronic Spontaneous Urticaria Trials in st louis, united states
Conditions / Chronic Spontaneous Urticaria / st louis, united states
Chronic Spontaneous Urticaria is a medical condition with active clinical research programs worldwide.
19 total trials for this combination
Showing top 10 of 19 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04833855 | Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria | COMPLETED | PHASE2 |
| NCT06077773 | Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria | TERMINATED | PHASE2 |
| NCT04210843 | Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab | TERMINATED | PHASE3 |
| NCT05513001 | An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04180488 | Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) | COMPLETED | PHASE3 |
| NCT05528861 | A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria | TERMINATED | PHASE2 |
| NCT03580356 | A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines. | COMPLETED | PHASE3 |
| NCT06455202 | A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02477332 | Dose-finding Study of QGE031 as add-on Therapy to Evaluate Efficacy and Safety in Patients With CSU | COMPLETED | PHASE2 |
| NCT05030311 | A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1 Antihistamines | COMPLETED | PHASE3 |